Multiple endocrine neoplasia-1 (MEN-1) presenting as primary hyperaldosteronism - A rare association

被引：0

作者：

Bhansali, Anil ^{[1
]}

Chanukya, G. V. ^{[1
]}

Bhadada, Sanjay Kumar ^{[1
]}

Behera, Arunanshu ^{[2
]}

Das Radotra, Bishan ^{[3
]}

机构：

[1] Postgrad Inst Med Educ & Res, Dept Endocrinol, Chandigarh 160012, India

[2] Postgrad Inst Med Educ & Res, Dept Surg, Chandigarh 160012, India

[3] Postgrad Inst Med Educ & Res, Dept Pathol, Chandigarh 160012, India

来源：

ENDOCRINOLOGIST | 2008年 / 18卷 / 02期

关键词：

primary hyperaldosteronism; multiple endocrine neoplasia; primary hyperparathyroidism; prolactinoma;

D O I：

10.1097/TEN.0b013e318169e432

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Multiple endocrine neoplasia-1 (MEN-1) is characterized by multiple endocrine tumors including parathyroid, islets of Langerhans, pituitary, and adrenal tumors. Most of these patients present with primary hyperparathyroidism. The adrenal tumors in MEN-1 are rare and usually bilateral and nonfunctional. To the best of our knowledge, this is the first report of primary hyperaldosteronism due to an adenoma as the presenting manifestation of MEN-1.

引用

页码：68 / 70

页数：3

共 50 条

[31] A single-institution experience of type-1 multiple endocrine neoplasia (MEN-1)-associated gastrinoma
Alharethi, S.
Thomson, S. R.
Bornman, P. C.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2012, 102 (08): : 708 - 708
[32] EMERGENCE OF FAMILIAL MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 (MEN-1) WITH AGGRESSIVE EXPRESSION AND HIGH PENETRANCE
GIRAUDPINLOCHE, S
CALENDER, A
CHOPLIN, H
CHAYVIALLE, JA
LENOIR, GM
HAMON, P
GASTROENTEROLOGY, 1994, 106 (04) : A294 - A294
[33] PROLACTIN SECRETING ADENOMA AS PART OF MULTIPLE ENDOCRINE NEOPLASIA TYPE-I (MEN-1) SYNDROME
ROSEBROCK, GL
LEVINE, JH
SAGEL, J
NAIR, RMG
GONZALEZ, JJ
RAWE, S
POWERS, JM
CLINICAL RESEARCH, 1978, 26 (01): : A16 - A16
[34] Multiple endocrine neoplasia type 1 (MEN 1)
不详
MEDICINA DELLO SPORT, 2007, 60 (03) : 407 - 411
[35] Multiple Endocrine Neoplasia Type 1 (MEN-1), the Hadassah-Hebrew University Medical Center Experience.
Kassem, S.
Glaser, B.
Barak, D.
Fraenkel, M.
Gross, D. J.
ENDOCRINE REVIEWS, 2010, 31 (03)
[36] Co-existence of glucagonoma with recurrent insulinoma in a patient with multiple endocrine neoplasia-type 1 (MEN-1)
Nishiuchi, Takamasa
Imachi, Hitomi
Murao, Koji
Fujiwara, Mako
Muraoka, Tomie
Kikuchi, Fumi
Nishiuchi, Yukiko
Kushida, Yoshio
Haba, Reiji
Ishida, Toshihiko
ENDOCRINE, 2009, 36 (01) : 20 - 24
[37] Treatment of a thyrotropinoma with octreotide-LAR in a patient with multiple endocrine neoplasia-1
Taylor, TJ
Donlon, SS
Bale, AE
Smallridge, RC
Francis, TB
Christensen, RS
Burman, KD
THYROID, 2000, 10 (11) : 1001 - 1007
[38] Co-existence of glucagonoma with recurrent insulinoma in a patient with multiple endocrine neoplasia-type 1 (MEN-1)
Takamasa Nishiuchi
Hitomi Imachi
Koji Murao
Mako Fujiwara
Tomie Muraoka
Fumi Kikuchi
Yukiko Nishiuchi
Yoshio Kushida
Reiji Haba
Toshihiko Ishida
Endocrine, 2009, 36 : 20 - 24
[39] LINKAGE AND CLINICAL ANALYSIS IN THE IDENTIFICATION OF HIGH-RISK FAMILY MEMBERS WITH MULTIPLE ENDOCRINE NEOPLASIA-1 (MEN1)
THIRUKKUMARAN, P
SAWICKI, MP
GRATTON, KJ
JOHNSON, CJ
AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 1763 - 1763
[40] IMPLICATION OF MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 (MEN-1) GENE IN THE OCCURRENCE OF A FUNDIC ARGYROPHIL CARCINOID-TUMOR IN A PATIENT WITH ZOLLINGER-ELLISON SYNDROME AND MEN-1
LAURENTPUIG, P
CADIOT, G
THUILLE, B
LEHY, T
MIGNON, M
LEWIN, MJM
OLSCHWANG, S
GASTROENTEROLOGY, 1993, 104 (04) : A419 - A419

← 1 2 3 4 5 →